10-Baggas Factory 10

[Robertscott]

$IMLFF the company is continuing drug/disease target identification using their proprietary bioinformatics analysis tool, More robust analysis of existing datasets to ensure that their clinical development plans are accurate and positioned to maximize the likelihood for positive outcomes, Validation and advancement of the biosynthesis manufacturing process; filing of provisional patents to commercially protect this key invention, Expanded scope of opportunities for cannabinoid-based drugs by validating new drug/disease targets in in vitro and in vivo efficacy model